Dr. Mohammad Ali Aziz-Sultan, MD, MBA

Dr. Sultan is a neurosurgeon at Mass General Brigham specializing in cerebrovascular diseases and stroke. He is the founding Director of the Mass General Brigham Global Neurosurgery Program. With a clinical focus comprising 80% of his time, Dr. Sultan integrates innovation, surgical expertise, and systems-level thinking to enhance care delivery, medical education, and global health. He is also the founder and Chair of the Afghan American Community Organization, the largest U.S.-based Afghan diaspora group dedicated to mentorship, advocacy, and education.

Renowned for pioneering techniques in vascular tumor embolization and hybrid cerebrovascular procedures, Dr. Sultan has led groundbreaking clinical trials and contributed over 200 peer-reviewed publications and 30 book chapters. His innovations—including direct ophthalmic artery chemotherapy for retinoblastoma and early adoption of flow-diverting stents—have helped reshape treatment paradigms worldwide. A graduate of the MIT Sloan MBA program, he brings a unique perspective on health system optimization, having co-authored pivotal studies that have influenced national stroke guidelines and helped identify barriers to access in both U.S. and global settings.

An educator and mentor at heart, Dr. Sultan has trained more than 80 residents and fellows, many of whom now lead academic programs around the world. His commitment to global neurosurgery includes launching virtual training for Afghan surgeons and delivering humanitarian aid during conflict. A Distinguished Clinician at Brigham and Women’s Hospital and an inducted member of the World Academy of Neurological Surgery, he continues to shape the future of neurosurgical care through leadership, research, and a steadfast commitment to equity and excellence in medicine.